Similarly, EPAC1 expression is enhanced in human ovarian cancer cells, and silencing EPAC1 with short interfering RNA decreases proliferation and promotes cell cycle arrest in vitro as well as suppressing tumor development in vivo in xenograft nude mouse models. This evidence concerns the gene RAPGEF3 and ovarian cancer.